Scientists turn on the 'gender lens' on cardiovascular disease research

December 10, 2004

Hamilton, ON (Dec. 8, 2004) - Hamilton health scientists are turning the "gender lens" on the different ways women and men are affected by cardiovascular disease.

A team of clinician-investigators jointly affiliated with McMaster University and Hamilton Health Sciences has formed the GRACE or Gender Research and Cardiovascular Evaluation Network. The goal of the network is to perform high quality gender-based research in cardiovascular disease, train new researchers and ensure the research results are widely available and accessible to the Canadian public.

The network team leader is Dr. Sonia Anand, an associate professor in the Michael G. DeGroote School of Medicine of the Faculty of Health Sciences, McMaster University. She holds the Eli Lilly Canada - May Cohen Chair in Women's Health at McMaster University and is a recipient of the Canadian Institutes of Health Research Clinician-Scientist Award. As well, Dr. Anand is director of the vascular medicine clinic at Hamilton Health Sciences.

GRACE investigators will focus specifically on two areas: acute coronary syndrome and the metabolic syndrome, also known as type-2 diabetes linked with abdominal obesity.

"We will focus on assessing epidemiological studies and clinical trials in these two important problem areas," said Dr. Anand. "We will be analyzing data with a gender lens, asking questions such as 'Is it appropriate that women with heart disease receive fewer angiograms, compared to men?'"

Another emphasis for the network is to ensure the study results are widely communicated to a broad national audience.

"We want to get the health message out to people so they are aware and can make use of it," Dr. Anand said. "We usually only publish our papers in scientific journals and sometimes the message doesn't get out in a simple, usable way."

In a bid to enhance the transfer of knowledge from the scientific community to the general public, Dr. Anand has formed an advisory board, chaired by Maureen McTeer, which will assist with generating novel approaches to communicating research findings. McTeer is a prominent Canadian lawyer with expertise in medical and reproductive health issues. Other members of the advisory board include former Hamilton MP Sheila Copps, CTV medical correspondent Avis Favaro, Dr. May Cohen and Murray Martin, President and CEO of Hamilton Health Sciences.

The advisory board is holding its first meeting at McMaster University on Thursday, Dec. 9, from 9 a.m. to noon.

Dr. Anand was awarded about $1 million over five years by the Canadian Institutes of Health Research and the Heart and Stroke Foundation to establish the GRACE Network. Clinician-scientists involved in the network include Dr. Salim Yusuf, Professor Heather Arthur, Dr. Stefan Blankenberg, Dr. Hertzel Gerstein, Dr. Eva Lonn, Dr. Madhu Natarajan and Dr. Shamir Mehta.

John Capone, associate dean, research, Faculty of Health Sciences, McMaster University, said: "The crucial importance of gender differences in disease development, treatment, diagnosis and prevention is becoming increasingly recognized, and the medical research community is focusing much needed attention on this area. The research being led by Dr. Anand will benefit the health of all Canadians as it will lead to a better understanding of gender-based differences in cardiovascular disease and diabetes and, of equal importance, will communicate the knowledge gained to the medical community and to the public."

Hamilton Health Sciences President Murray Martin said: "I am very pleased to be asked to sit on the advisory board with Ms. McTeer and others as this is very important research that needs to be done. Our family of hospitals is wholeheartedly committed to equity and equality. Some issues, to be properly dealt with from a policy perspective, must first be looked at through the lens of research."
-end-
For more information please contact:

Shelly Easton, Hamilton Health Sciences
905-521-2100 ext. 76731
Pager 905-540-0301
eastons@hhsc.ca

Veronica McGuire, McMaster University
905-525-9140, ext. 22619
vmcguir@mcmaster.ca

--
Shelly Easton
Senior Public Relations Specialist
Public Relations and Communications
Hamilton Health Sciences
T: 905-521-2100 ext. 76731
Pager: 905-540-0301
Email: eastons@hhsc.ca
Web: www.hamiltonhealthsciences.ca

McMaster University

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.